PANDION THERAPEUTICS, INC. Depreciation
PANDION THERAPEUTICS, INC. reported Depreciation of $512.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2021-03-12
- PANDION THERAPEUTICS, INC. depreciation for the quarter ending 2020-12-31 was $183.00K, a 181.54% increase year-over-year.
- PANDION THERAPEUTICS, INC. depreciation for the quarter ending 2020-09-30 was $158.00K, a 143.08% increase year-over-year.
- PANDION THERAPEUTICS, INC. depreciation for the quarter ending 2019-12-31 was $65.00K.
- PANDION THERAPEUTICS, INC. depreciation for the quarter ending 2019-09-30 was $65.00K.
- PANDION THERAPEUTICS, INC. depreciation for fiscal 2020 was $512.00K, a 111.57% increase from fiscal 2019.
- PANDION THERAPEUTICS, INC. depreciation for fiscal 2019 was $242.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2020-12-31 | $183.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $341.00K derived: sum of 2 quarters · filed 2021-03-12 | $512.00K 10-K · filed 2021-03-12 | |
| 2020-09-30 | $158.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $329.00K 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | $171.00K 10-Q · filed 2020-08-31 | |||
| 2019-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $130.00K derived: sum of 2 quarters · filed 2021-03-12 | $242.00K 10-K · filed 2021-03-12 | |
| 2019-09-30 | $65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $177.00K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $112.00K 10-Q · filed 2020-08-31 |